EPISODE · Dec 2, 2013 · 9 MIN
Increasing Cytarabine Dose in AML Induction Improves Outcomes in Younger Patients
from Journal of Clinical Oncology (JCO) Podcast
This podcast describes the recent experience of high dose cytarabine induction in patients with acute myeloid leukemia (AML), as reported in the EORTCGIMEMA AML-12 trial. The podcast includes a summary of the trial and discussion of the implications of the finding that high dose cytarabine induction improves outcomes in younger patients with AML.
Embed this episode
NOW PLAYING
Increasing Cytarabine Dose in AML Induction Improves Outcomes in Younger Patients
0:00
9:00
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Journal of Clinical Oncology (JCO) Podcast?
This episode is 9 minutes long.
When was this Journal of Clinical Oncology (JCO) Podcast episode published?
This episode was published on December 2, 2013.
Can I download this Journal of Clinical Oncology (JCO) Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!